CCCDTD5: Reducing the risk of later-life dementia. Evidence informing the Fifth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD-5)

Kenneth Rockwood; Melissa K. Andrew; Mylène Aubertin-Leheudre; Sylvie Belleville; Louis Bherer; Susan K. Bowles; D. Scott Kehler; Andrew Lim; Laura Middleton; Natalie Phillips; Lindsay M.K. Wallace

doi:10.1002/trc2.12083

CCCDTD5: Reducing the risk of later-life dementia. Evidence informing the Fifth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD-5)

Kenneth Rockwood, Melissa K. Andrew, Mylène Aubertin-Leheudre, Sylvie Belleville, Louis Bherer, Susan K. Bowles, D. Scott Kehler, Andrew Lim, Laura Middleton, Natalie Phillips, Lindsay M.K. Wallace

Producción científica: Contribución a una revista › Artículo › revisión exhaustiva

12 Citas (Scopus)

Resumen

The Fifth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD-5) was a year-long process to synthesize the best available evidence on several topics. Our group undertook evaluation of risk reduction, in eight domains: nutrition; physical activity; hearing; sleep; cognitive training and stimulation; social engagement and education; frailty; and medications. Here we describe the rationale for the undertaking and summarize the background evidence—this is also tabulated in the Appendix. We further comment specifically on the relationship between age and dementia, and offer some suggestions for how reducing the risk of dementia in the seventh decade and beyond might be considered if we are to improve prospects for prevention in the near term. We draw to attention that a well-specified model of success in dementia prevention need not equate to the elimination of cognitive impairment in late life.

Idioma original	English
Número de artículo	e12083
Publicación	Alzheimer's and Dementia: Translational Research and Clinical Interventions
Volumen	6
N.º	1
DOI	https://doi.org/10.1002/trc2.12083
Estado	Published - 2020

Nota bibliográfica

Funding Information:
Melissa K. Andrew: reports grant funding from GSK, Pfizer, and Sanofi and payments from Sanofi and Pfizer for research on frailty in relation to vaccine preventable illnesses.

Funding Information:
Susan K Bowles has received funding from the Canadian Frailty Network to evaluate interventions to decrease the Drug Burden Index.

Publisher Copyright:
© 2020 The Authors. Alzheimer's & Dementia: Translational Research & Clinical Interventions published by Wiley Periodicals, Inc. on behalf of Alzheimer's Association.

ASJC Scopus Subject Areas

Clinical Neurology
Psychiatry and Mental health

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

Acceder al documento

10.1002/trc2.12083

Otros archivos y enlaces

Citar esto

Rockwood, K., Andrew, M. K., Aubertin-Leheudre, M., Belleville, S., Bherer, L., Bowles, S. K., Kehler, D. S., Lim, A., Middleton, L., Phillips, N., & Wallace, L. M. K. (2020). CCCDTD5: Reducing the risk of later-life dementia. Evidence informing the Fifth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD-5). Alzheimer's and Dementia: Translational Research and Clinical Interventions, 6(1), Artículo e12083. https://doi.org/10.1002/trc2.12083

CCCDTD5: Reducing the risk of later-life dementia. Evidence informing the Fifth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD-5). / Rockwood, Kenneth ; Andrew, Melissa K.; Aubertin-Leheudre, Mylène et al.
En: Alzheimer's and Dementia: Translational Research and Clinical Interventions, Vol. 6, N.º 1, e12083, 2020.

Producción científica: Contribución a una revista › Artículo › revisión exhaustiva

Rockwood, K , Andrew, MK, Aubertin-Leheudre, M, Belleville, S, Bherer, L, Bowles, SK, Kehler, DS, Lim, A, Middleton, L, Phillips, N & Wallace, LMK 2020, 'CCCDTD5: Reducing the risk of later-life dementia. Evidence informing the Fifth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD-5)', Alzheimer's and Dementia: Translational Research and Clinical Interventions, vol. 6, n.º 1, e12083. https://doi.org/10.1002/trc2.12083

@article{974817534469468b8bef42f3f95ffe03,

title = "CCCDTD5: Reducing the risk of later-life dementia. Evidence informing the Fifth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD-5)",

abstract = "The Fifth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD-5) was a year-long process to synthesize the best available evidence on several topics. Our group undertook evaluation of risk reduction, in eight domains: nutrition; physical activity; hearing; sleep; cognitive training and stimulation; social engagement and education; frailty; and medications. Here we describe the rationale for the undertaking and summarize the background evidence—this is also tabulated in the Appendix. We further comment specifically on the relationship between age and dementia, and offer some suggestions for how reducing the risk of dementia in the seventh decade and beyond might be considered if we are to improve prospects for prevention in the near term. We draw to attention that a well-specified model of success in dementia prevention need not equate to the elimination of cognitive impairment in late life.",

author = "Kenneth Rockwood and Andrew, {Melissa K.} and Myl{\`e}ne Aubertin-Leheudre and Sylvie Belleville and Louis Bherer and Bowles, {Susan K.} and Kehler, {D. Scott} and Andrew Lim and Laura Middleton and Natalie Phillips and Wallace, {Lindsay M.K.}",

note = "Funding Information: Melissa K. Andrew: reports grant funding from GSK, Pfizer, and Sanofi and payments from Sanofi and Pfizer for research on frailty in relation to vaccine preventable illnesses. Funding Information: Susan K Bowles has received funding from the Canadian Frailty Network to evaluate interventions to decrease the Drug Burden Index. Publisher Copyright: {\textcopyright} 2020 The Authors. Alzheimer's & Dementia: Translational Research & Clinical Interventions published by Wiley Periodicals, Inc. on behalf of Alzheimer's Association.",

year = "2020",

doi = "10.1002/trc2.12083",

language = "English",

volume = "6",

journal = "Alzheimer's and Dementia: Translational Research and Clinical Interventions",

issn = "2352-8737",

publisher = "Elsevier Inc.",

number = "1",

}

TY - JOUR

T1 - CCCDTD5

T2 - Reducing the risk of later-life dementia. Evidence informing the Fifth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD-5)

AU - Rockwood, Kenneth

AU - Andrew, Melissa K.

AU - Aubertin-Leheudre, Mylène

AU - Belleville, Sylvie

AU - Bherer, Louis

AU - Bowles, Susan K.

AU - Kehler, D. Scott

AU - Lim, Andrew

AU - Middleton, Laura

AU - Phillips, Natalie

AU - Wallace, Lindsay M.K.

N1 - Funding Information: Melissa K. Andrew: reports grant funding from GSK, Pfizer, and Sanofi and payments from Sanofi and Pfizer for research on frailty in relation to vaccine preventable illnesses. Funding Information: Susan K Bowles has received funding from the Canadian Frailty Network to evaluate interventions to decrease the Drug Burden Index. Publisher Copyright: © 2020 The Authors. Alzheimer's & Dementia: Translational Research & Clinical Interventions published by Wiley Periodicals, Inc. on behalf of Alzheimer's Association.

PY - 2020

Y1 - 2020

N2 - The Fifth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD-5) was a year-long process to synthesize the best available evidence on several topics. Our group undertook evaluation of risk reduction, in eight domains: nutrition; physical activity; hearing; sleep; cognitive training and stimulation; social engagement and education; frailty; and medications. Here we describe the rationale for the undertaking and summarize the background evidence—this is also tabulated in the Appendix. We further comment specifically on the relationship between age and dementia, and offer some suggestions for how reducing the risk of dementia in the seventh decade and beyond might be considered if we are to improve prospects for prevention in the near term. We draw to attention that a well-specified model of success in dementia prevention need not equate to the elimination of cognitive impairment in late life.

AB - The Fifth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD-5) was a year-long process to synthesize the best available evidence on several topics. Our group undertook evaluation of risk reduction, in eight domains: nutrition; physical activity; hearing; sleep; cognitive training and stimulation; social engagement and education; frailty; and medications. Here we describe the rationale for the undertaking and summarize the background evidence—this is also tabulated in the Appendix. We further comment specifically on the relationship between age and dementia, and offer some suggestions for how reducing the risk of dementia in the seventh decade and beyond might be considered if we are to improve prospects for prevention in the near term. We draw to attention that a well-specified model of success in dementia prevention need not equate to the elimination of cognitive impairment in late life.

UR - http://www.scopus.com/inward/record.url?scp=85095953645&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85095953645&partnerID=8YFLogxK

U2 - 10.1002/trc2.12083

DO - 10.1002/trc2.12083

M3 - Article

AN - SCOPUS:85095953645

SN - 2352-8737

VL - 6

JO - Alzheimer's and Dementia: Translational Research and Clinical Interventions

JF - Alzheimer's and Dementia: Translational Research and Clinical Interventions

IS - 1

M1 - e12083

ER -

CCCDTD5: Reducing the risk of later-life dementia. Evidence informing the Fifth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD-5)

Resumen

Nota bibliográfica

ASJC Scopus Subject Areas

ODS de las Naciones Unidas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto